Association of body mass index with cardiac reverse remodeling and long-term outcome in advanced heart failure patients with cardiac resynchronization therapy

Circulation Journal

Volumn 78, Issue 12, 2014, Pages 2899-2907

  Cai, Chi ^a   Hua, Wei ^a   Ding, Li Gang ^a   Wang, Jing ^a   Chen, Ke Ping ^a   Yang, Xin Wei ^a   Liu, Zhi Min ^a   Zhang, Shu ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Body mass index; Cardiac resynchronization therapy; Clinical outcome; Heart failure

Indexed keywords

ADULT; ARTICLE; BODY MASS; CARDIAC RESYNCHRONIZATION THERAPY; COMORBIDITY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART VENTRICLE REMODELING; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; OBSERVATIONAL STUDY; PROGNOSIS; RETROSPECTIVE STUDY; AGED; CARDIOVERSION; CAUSE OF DEATH; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART STROKE VOLUME; MIDDLE AGED; OVERWEIGHT; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL;

BIOLOGICAL MARKER;

ADIPOSITY; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; CARDIAC RESYNCHRONIZATION THERAPY; CAUSE OF DEATH; COMORBIDITY; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ELECTRIC COUNTERSHOCK; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR REMODELING;

EID: 84911881534     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-14-0812     Document Type: Article

References (24)

1. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-1549.
2. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346: 1845-1853.
3. JCS Joint Working Group. Guidelines for non-pharmacotherapy of cardiac arrhythmias (JCS 2011): Digest version. Circ J 2013; 77: 249-274.
4. Bax JJ, Gorcsan JR. Echocardiography and noninvasive imaging in cardiac resynchronization therapy: Results of the PROSPECT (Predictors of Response to Cardiac Resynchronization Therapy) study in perspective. J Am Coll Cardiol 2009; 53: 1933-1943.
5. Lavie CJ, Alpert MA, Arena R, Mehra MR, Milani RV, Ventura HO. Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. JACC Heart Fail 2013; 1: 93-102.
6. Komukai K, Minai K, Arase S, Ogawa T, Nakane T, Nagoshi T, et al. Impact of body mass index on clinical outcome in patients hospitalized with congestive heart failure. Circ J 2012; 76: 145-151.
7. Zhou BF. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults: Study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci 2002; 15: 83-96.
8. White JA, Yee R, Yuan X, Krahn A, Skanes A, Parker M, et al. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. J Am Coll Cardiol 2006; 48: 1953-1960.
9. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367.
10. Obesity: Preventing and managing the global epidemic: Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894: 1-253.
11. Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA. Body mass index and mortality in heart failure: A meta-analysis. Am Heart J 2008; 156: 13-22.
12. Richardson M, Freemantle N, Calvert MJ, Cleland JG, Tavazzi L. Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: A pre-defined analysis from the CARE-HF trial. Eur Heart J 2007; 28: 1827-1834.
13. Zareba W, Klein H, Cygankiewicz I, Hall WJ, McNitt S, Brown M, et al. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation 2011; 123: 1061-1072.
14. Shalaby A, Voigt A, El-Saed A, Saba S. Usefulness of pulmonary artery pressure by echocardiography to predict outcome in patients receiving cardiac resynchronization therapy heart failure. Am J Cardiol 2008; 101: 238-241.
15. Verbrugge FH, Dupont M, Vercammen J, Jacobs L, Verhaert D, Vandervoort P, et al. Time from emerging heart failure symptoms to cardiac resynchronisation therapy: Impact on clinical response. Heart 2013; 99: 314-319.
16. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: Risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009; 53: 1925-1932.
17. Davos CH, Doehner W, Rauchhaus M, Cicoira M, Francis DP, Coats AJ, et al. Body mass and survival in patients with chronic heart failure without cachexia: The importance of obesity. J Card Fail 2003; 9: 29-35.
18. Mohamed-Ali V, Goodrick S, Bulmer K, Holly JM, Yudkin JS, Coppack SW. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol 1999; 277: E971-E975.
19. Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, Flyvbjerg A, et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005; 112: 1756-1762.
20. Yin WH, Wei J, Huang WP, Chen JW, Young MS, Lin SJ. Prognostic value of circulating adipokine levels and expressions of adipokines in the myocardium of patients with chronic heart failure. Circ J 2012; 76: 2139-2147.
21. Frankenstein L, Remppis A, Nelles M, Schaelling B, Schellberg D, Katus H, et al. Relation of N-terminal pro-brain natriuretic peptide levels and their prognostic power in chronic stable heart failure to obesity status. Eur Heart J 2008; 29: 2634-2640.
22. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012; 14: 803-869.
23. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 2004; 79: 379-384.
24. Lavie CJ, Osman AF, Milani RV, Mehra MR. Body composition and prognosis in chronic systolic heart failure: The obesity paradox. Am J Cardiol 2003; 91: 891-894.